Company Overview and News


Add 506690
to your dashboard

Headline News

Torrent Pharma completes acquisition of Unichem's branded biz

2017-12-14 thehindubusinessline
Pharma major, Torrent Pharmaceuticals Limited on Thursday informed that the company has completed acquisition of branded businesses of Unichem Laboratories Limited for India and Nepal, including its Sikkim manufacturing facility, on a going concern basis by way of slump sale. The two companies had entered into a definitive binding agreement on November 3, 2017 with deal size put at ₹3,600 crore.

Unichem Laboratories Limited - Press Release

2017-12-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

India Inc#39;s November MA deal tally grows 55% to $3 bn: Report

2017-12-12 moneycontrol
India Inc's merger and acquisition activity registered a growth of 55 per cent year- on-year in November with deals worth USD 3.2 billion, powered by big-ticket transactions and revival in cross-border activity, says a report.

Unichem Laboratories Limited - Shareholders meeting

2017-12-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Unichem Laboratories Limited - Updates

2017-11-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Will continue to pursue inorganic growth in India US: Torrent Pharma

2017-11-07 moneycontrol
The big story from deal street is that Torrent Pharmaceuticals will acquire Unichem Laboratories' branded formulation business in India and Nepal. Torrent will spend Rs 3,600 crore for the acquisition, which is expected to close by the end of this year.

Unichem Laboratories Limited - Shareholders meeting

2017-11-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Deals Buzz: Everstone in talks to buy Kenstar, Crompton Greaves out of race

2017-11-06 livemint
Mumbai: Mint brings to you your daily dose of top deals reported by newsrooms across the country. (25-0)

Unichem shares rally 12% on Torrent Pharma deal, Q2 net profit

2017-11-06 thehindubusinessline
Shares of Unichem Laboratories jumped to a record high on strong profit and Torrent Pharma deal.

Unichem to return 50% of proceeds from Torrent deal to shareholders

2017-11-05 livemint
Mumbai: Unichem Laboratories Ltd plans to return to its shareholders more than 50% of net proceeds it will receive from the sale of domestic formulations business to Torrent Pharmaceuticals Ltd. It will use the rest to expand its international business, particularly in the US.

Torrent Pharma buys out Unichem, while Divis gets USFDA clearance; stocks in the sector on fire

2017-11-04 moneycontrol
Pharmaceutical stocks, which were lying low bounced back this past week with second quarter results largely in line with analyst expectations on recovery of domestic formulation business after disruption caused due to GST transition in the first quarter. Torrent Pharmaceuticals' acquisition of Indian branded business of Unichem Laboratories and USFDA lifting import ban on Divis Laboratories' Unit-II in Visakhapatnam are highlights of the week. (2-0)

Time to move to next orbit of growth: Unichem chief Mody

2017-11-04 thehindubusinessline
At the end of the day, every organisation needs to do what is in its best interest, says Dr Prakash Mody, Chairman of Unichem Laboratories, just minutes after the company announced the sale of its India and Nepal businesses to Torrent Pharma in a ₹3,600- crore transaction.

Torrent Pharma to buy Unichem’s India business

2017-11-04 livemint
Ahmedabad/Mumbai: Torrent Pharmaceuticals Ltd, the flagship company of the Ahmedabad-based Torrent group, on Friday said it had agreed to acquire the branded business of Unichem Laboratories Ltd in India and Nepal for Rs3,600 crore.

Torrent Pharma to acquire Unichem for Rs 3,600 cr

2017-11-04 freepressjournal.in
New Delhi : Torrent Pharmaceuticals Friday said it will acquire branded business of Unichem Laboratories in India and Nepal for Rs 3,600 crore in one of the major consolidations in the domestic pharma sector.

Unichem Labs Q2 net profit at Rs 46 cr

2017-11-04 business-standard
Drug firm Unichem Laboratories on Friday reported a standalone net profit of Rs 45.82 crore for the second quarter ended on September 30, 2017. The company had posted a net profit of Rs 20.52 crore for the corresponding period of the previous fiscal, Unichem Laboratories said in a filing to BSE.